BA40 - Angina Pectoris: Complete ICD-11 Coding Guide

1. Introduction

Angina pectoris represents one of the most common manifestations of coronary artery disease, characterized by chest pain or discomfort resulting from transient myocardial ischemia. This cardiac symptom arises when the oxygen supply to the heart muscle is insufficient to meet its metabolic demands, typically during physical exertion or emotional stress.

The clinical importance of angina pectoris transcends its symptomatic presentation, functioning as a crucial warning sign for underlying coronary disease. Healthcare professionals recognize this condition as a significant predictor of major cardiovascular events, including acute myocardial infarction and sudden cardiac death. The prevalence of this condition increases progressively with age, affecting millions of people globally and representing one of the leading causes of cardiology consultations in emergency departments and specialized outpatient services.

From a public health perspective, angina pectoris imposes a substantial burden on healthcare systems worldwide. Patients with angina frequently experience significant functional limitations, reduced quality of life, and need for continuous medical follow-up. The economic impact includes direct costs related to diagnostic investigations, medications, and revascularization procedures, as well as indirect costs associated with loss of work productivity.

Correct coding of angina pectoris using the BA40 code from ICD-11 is fundamental for multiple purposes: it ensures accurate clinical documentation, facilitates epidemiological studies, allows appropriate allocation of health resources, assures appropriate reimbursements, and enables monitoring of trends in cardiovascular health. Accuracy in coding also assists in risk stratification, therapeutic planning, and evaluation of clinical outcomes in patient populations.

2. Correct ICD-11 Code

Code: BA40

Description: Angina pectoris

Parent category: Acute ischemic heart disease

The code BA40 in the ICD-11 classification specifically identifies angina pectoris as a distinct clinical entity within the spectrum of acute ischemic heart diseases. This classification recognizes angina as a manifestation of reversible myocardial ischemia, clearly differentiating it from ischemic events that result in permanent myocardial necrosis.

The hierarchical structure of ICD-11 positions code BA40 within a broader context of cardiovascular conditions, allowing healthcare professionals and coders to quickly identify the acute ischemic nature of the condition, without the presence of irreversible myocardial damage. This distinction is clinically crucial, as angina pectoris, although serious, represents a potentially reversible stage of coronary artery disease.

Code BA40 encompasses various forms of angina presentation, including stable angina (triggered by predictable exertion), unstable angina (pattern of recent onset, progressive worsening, or occurrence at rest), and vasospastic angina (caused by coronary artery spasm). The flexibility of this code allows its application in different clinical contexts, from routine outpatient care to emergency situations, while maintaining the diagnostic specificity necessary for appropriate patient management.

3. When to Use This Code

The code BA40 should be used in specific clinical scenarios where angina pectoris is the established primary diagnosis. Below, we present detailed practical situations:

Scenario 1: Patient with Chronic Stable Angina A 62-year-old patient presents with a history of chest pain described as tightness, retrosternal in location, occurring consistently when climbing stairs or walking briskly, completely relieved with rest in 3-5 minutes. The exercise stress test demonstrates ST segment depression during exertion, without elevation of cardiac markers. Coronary angiography reveals significant coronary stenosis without complete occlusion. This is a typical case for BA40 coding, representing stable effort angina with documented ischemia.

Scenario 2: Angina at Rest without Myocardial Infarction Patient evaluated in the emergency department with an episode of chest pain at rest, lasting 15 minutes, with typical anginal characteristics. Initial evaluation shows transient electrocardiographic changes (ST segment depression or T wave inversion); however, myocardial necrosis markers (troponins) remain within normal limits on serial measurements. This presentation of unstable angina without evidence of infarction justifies the BA40 code.

Scenario 3: Vasospastic Angina (Prinzmetal) Patient reports episodes of severe chest pain occurring predominantly during the early morning hours or at rest, unrelated to physical exertion. Electrocardiographic monitoring during episodes demonstrates transient ST segment elevation that normalizes spontaneously or with sublingual nitrate. Provocative testing may confirm coronary vasospasm. Cardiac markers remain normal. The BA40 code is appropriate for this specific form of angina.

Scenario 4: Newly Onset Angina Previously asymptomatic patient develops chest pain with moderate exertion over the past three weeks. Investigation includes positive exercise electrocardiogram for ischemia, stress echocardiogram demonstrating segmental wall motion abnormalities, and normal troponins. The diagnosis of newly onset angina, without evidence of prior or current infarction, fits perfectly within the BA40 code.

Scenario 5: Angina Post-Revascularization Patient previously undergoing myocardial revascularization (surgical or percutaneous) who develops recurrence of anginal symptoms. Evaluation demonstrates myocardial ischemia without acute infarction, possibly related to progression of atherosclerotic disease or graft dysfunction. In the absence of myocardial necrosis, the BA40 code is appropriate for documenting recurrent angina.

Scenario 6: Microvascular Angina Patient with typical anginal symptoms, functional tests demonstrating myocardial ischemia; however, coronary angiography showing epicardial coronary arteries without significant obstructions. Coronary microvascular dysfunction is identified through specific coronary flow reserve testing. This type of angina, although with different pathophysiology, is still coded as BA40.

4. When NOT to Use This Code

It is essential to recognize situations where code BA40 is not appropriate, avoiding coding errors that may compromise clinical documentation and patient management.

Main Exclusion: Acute Myocardial Infarction Code BA40 should NOT be used when there is evidence of acute myocardial necrosis. If the patient presents with elevation of cardiac markers (troponins) above the 99th percentile of the upper reference limit, combined with ischemic symptoms or compatible electrocardiographic changes, the diagnosis is acute myocardial infarction (BA41), not angina pectoris.

Exclusion: Prior Infarction as Principal Diagnosis When the clinical focus is a subsequent or recurrent myocardial infarction (BA42), even if the patient has a history of angina, code BA40 should not be the principal diagnosis. Angina may be listed as a coexisting condition, but the acute infarction event takes priority in coding.

Exclusion: Coronary Thrombosis without Infarction Code BA43 (coronary thrombosis that does not result in myocardial infarction) is more specific when there is documented evidence of acute coronary thrombosis without development of myocardial necrosis. Although clinically related to angina, this more specific code should be preferred when thrombosis is confirmed by imaging methods.

Exclusion: Non-Cardiac Chest Pain Chest pain of musculoskeletal, gastrointestinal (esophageal reflux, esophageal spasm), pulmonary (pulmonary embolism, pneumothorax), or psychogenic origin should not be coded as BA40. Coding of angina pectoris requires confirmation of ischemic cardiac origin through appropriate clinical evaluation and, ideally, confirmatory diagnostic tests.

Exclusion: Indeterminate Acute Coronary Syndrome During initial evaluation of acute chest pain, when there is still no clear differentiation between unstable angina and acute myocardial infarction (awaiting results of serial cardiac markers), it may be more appropriate to use provisional or more general codes until the definitive diagnosis is established.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

Diagnostic confirmation of angina pectoris begins with detailed clinical evaluation. The clinical history should identify typical characteristics of anginal pain: quality (tightness, pressure, heaviness), location (retrosternal, potentially radiating to jaw, neck, shoulders, or arms), duration (typically 2-10 minutes), and triggering factors (physical exertion, emotional stress, cold).

Physical examination during an anginal episode may be normal or reveal signs of transient ventricular dysfunction. The evaluation should include electrocardiogram, preferably during symptoms, which may demonstrate ischemic changes (transient ST segment depression or elevation, T wave inversion). Cardiac biomarkers (troponins) should be measured to exclude myocardial necrosis.

Complementary diagnostic tests include exercise stress test, stress echocardiography (physical or pharmacological), myocardial perfusion scintigraphy, or cardiac magnetic resonance imaging. Coronary angiography or coronary angiography computed tomography may be necessary for anatomical evaluation of coronary arteries. Confirmation of reversible myocardial ischemia without evidence of infarction is essential for diagnosis.

Step 2: Verify Specifiers

After confirming the diagnosis of angina pectoris, it is important to characterize the specific type. Stable angina presents a predictable pattern, triggered by a consistent level of exertion, with relatively constant duration and intensity. Unstable angina is characterized by recent onset (less than two months), increasing pattern (increase in frequency, intensity, or duration), or occurrence at rest.

Functional severity can be classified according to established criteria: Class I (angina only with strenuous exertion), Class II (mild limitation of usual activities), Class III (significant limitation of usual activities), and Class IV (angina at rest or with minimal exertion). This stratification, although it does not change the code BA40, is important for complete clinical documentation.

Special characteristics such as vasospastic angina (predominantly at rest, with transient ST segment elevation) or microvascular angina (normal epicardial arteries) should be documented in the clinical description, as they may influence therapeutic decisions while maintaining the code BA40.

Step 3: Differentiate from Other Codes

BA41 (Acute Myocardial Infarction): The fundamental difference is the presence of myocardial necrosis. In infarction, there is elevation of troponins above the 99th percentile of the upper reference limit, combined with clinical evidence of myocardial ischemia. Angina (BA40) does not present significant elevation of necrosis markers, representing reversible ischemia without permanent myocardial damage.

BA42 (Subsequent Myocardial Infarction): This code applies specifically to recurrent infarction events or reinfarctions. Even if the patient has a history of chronic angina, if a new infarction develops documented by elevation of biomarkers and electrocardiographic or imaging changes, code BA42 is more appropriate than BA40 for the current acute event.

BA43 (Coronary Thrombosis without Infarction): When there is specific documentation of acute coronary thrombosis (by angiography, angiography computed tomography, or autopsy) without development of myocardial infarction, code BA43 is more precise. Angina pectoris (BA40) generally does not have documented thrombosis as a mechanism, being more frequently related to stable atherosclerotic stenosis or coronary spasm.

Step 4: Necessary Documentation

Adequate documentation to justify code BA40 should include: detailed description of symptoms (quality, location, duration, triggering and relieving factors), physical examination findings during and outside anginal episodes, and electrocardiogram results (especially during symptoms).

Cardiac biomarker results (troponins) should be documented as normal or not significantly elevated. Reports of functional tests (exercise stress test, stress echocardiography, perfusion scintigraphy) demonstrating reversible ischemia should be included when available.

If performed, the description of coronary angiography or coronary angiography computed tomography should be present, detailing the presence and extent of coronary atherosclerotic disease. The documentation should clearly establish that there is no evidence of acute myocardial infarction, justifying the choice of code BA40 instead of BA41 or BA42.

Information about instituted treatment (antianginal medications, antiplatelet agents, statins), therapeutic response, and follow-up planning complement the documentation; although not strictly necessary for coding, they contribute to the complete clinical record.

6. Complete Practical Example

Clinical Case

A 58-year-old male patient, truck driver, seeks outpatient care reporting recurrent episodes of chest discomfort for approximately two months. He describes the sensation as "heaviness in the chest," located in the retrosternal region, without clear radiation, lasting 3 to 5 minutes.

The episodes occur consistently when the patient carries heavy loads or climbs stairs rapidly, relieving completely with rest or when he stops the activity. He denies symptom occurrence at rest or during the night. He reports that in recent days the episodes have become more frequent, occurring with progressively lesser exertion.

Past medical history reveals arterial hypertension under irregular treatment, dyslipidemia diagnosed three years ago, 30 pack-year smoking history. He denies diabetes mellitus, previous myocardial infarction, or prior cardiac procedures. Positive family history for coronary artery disease (father with myocardial infarction at age 55).

Physical examination: blood pressure 145/90 mmHg, heart rate 78 bpm regular, cardiac and pulmonary auscultation without abnormalities, palpable and symmetric peripheral pulses. Patient asymptomatic during the consultation.

Evaluation Performed

Resting electrocardiogram shows sinus rhythm, heart rate 76 bpm, without acute ischemic changes, presence of mild left ventricular overload. High-sensitivity troponin I assays were requested, which returned a value of 8 ng/L (normal up to 26 ng/L for men).

Exercise stress test performed using Bruce protocol: test interrupted at the 6th minute (stage II) due to typical chest pain and physical fatigue. Horizontal ST segment depression of 2 mm observed in precordial leads V4-V6 and inferior leads (DII, DIII, aVF) at peak exertion, with gradual normalization during recovery. Adequate blood pressure and chronotropic response.

Transthoracic echocardiogram: global systolic function preserved (ejection fraction 58%), mild concentric left ventricular hypertrophy, without segmental contractility abnormalities at rest, grade I diastolic function.

Lipid profile: total cholesterol 245 mg/dL, LDL 168 mg/dL, HDL 38 mg/dL, triglycerides 195 mg/dL. Fasting glucose 102 mg/dL, glycated hemoglobin 5.8%, normal renal function.

Diagnostic Reasoning

The patient presents with clinical presentation compatible with angina pectoris of recently progressive pattern. The characteristics of the pain (quality, location, duration, relationship with exertion and relief with rest) are typical of angina. The presence of multiple cardiovascular risk factors (age, male sex, hypertension, dyslipidemia, smoking, family history) significantly increases the pretest probability of coronary artery disease.

The positive exercise stress test for myocardial ischemia (typical electrocardiographic changes associated with reproduced anginal symptoms) objectively confirms the presence of exertion-induced myocardial ischemia. The normalization of changes during recovery demonstrates the reversibility of ischemia, a fundamental characteristic of angina.

The absence of elevation of myocardial necrosis markers (normal troponin) excludes acute myocardial infarction. The preserved ventricular function and absence of segmental changes at rest indicate that no significant prior infarction has occurred. The pattern of progressive symptoms in recent weeks suggests angina of unstable character, but without progression to acute coronary syndrome with necrosis.

Step-by-Step Coding

Criteria Analysis:

Typical symptoms of angina pectoris confirmed ✓
Myocardial ischemia documented by functional test ✓
Myocardial necrosis markers normal ✓
Absence of acute or prior infarction ✓
Clear relationship with physical exertion ✓

Code Selected: BA40 - Angina pectoris

Complete Justification: The code BA40 is appropriate because the patient presents with clinical manifestation of reversible myocardial ischemia (angina pectoris) without evidence of myocardial necrosis. The positive exercise stress test objectively confirms exertion-induced ischemia. Normal troponins exclude acute myocardial infarction (which would be coded as BA41). There is no history of prior infarction that would justify code BA42. There is no documentation of acute coronary thrombosis that would indicate code BA43.

Complementary Codes:

Essential arterial hypertension (appropriate code from category BA20-BA2Z)
Dyslipidemia (appropriate code from category 5C80-5C8Z)
Tobacco use (appropriate code from factors influencing health status)

This multiple coding approach allows complete documentation of the patient's cardiovascular risk profile, facilitating comprehensive therapeutic planning and appropriate risk stratification.

7. Related Codes and Differentiation

Within the Same Category

BA41: Acute Myocardial Infarction

Code BA41 should be used when there is evidence of acute myocardial necrosis, characterized by elevation of cardiac biomarkers (troponins) above the 99th percentile of the upper reference limit, associated with at least one of the following: symptoms of myocardial ischemia, new electrocardiographic changes compatible with ischemia (ST segment elevation or depression), development of pathological Q waves, or evidence by imaging methods of new loss of viable myocardium or new segmental wall motion abnormality.

Main difference vs. BA40: The presence of myocardial necrosis documented by elevation of cardiac markers is the fundamental differentiating criterion. In angina (BA40), ischemia is reversible without permanent damage to myocardial tissue, whereas in infarction (BA41) there is cell death documented biochemically and/or by imaging methods.

BA42: Subsequent Myocardial Infarction

This specific code applies to recurrent myocardial infarction episodes or reinfarction, occurring in patients with documented history of previous infarction. It includes situations where there is a new ischemic event with necrosis in a vascular territory different from the previous infarction, or reinfarction in the same territory after a period of stabilization.

Main difference vs. BA40: Code BA42 requires not only evidence of current myocardial necrosis (as in BA41), but also documented history of previous infarction. Patients with chronic angina (BA40) may have a history of previous infarction, but if they present only with reversible ischemia without a new necrotic event, the correct code remains BA40. If they develop a new infarction, the coding changes to BA42.

BA43: Coronary Thrombosis Not Resulting in Myocardial Infarction

Code BA43 identifies specific situations where there is documented acute coronary thrombosis (by angiography, coronary computed tomography angiography, or autopsy findings) without development of myocardial infarction. This may occur when thrombosis is rapidly resolved spontaneously or by therapeutic intervention before significant necrosis occurs.

Main difference vs. BA40: The specific documentation of acute coronary thrombosis is the distinguishing element. Angina pectoris (BA40) generally results from progressive atherosclerotic stenosis or coronary spasm, without documented acute thrombotic formation. When thrombosis is identified without resulting infarction, BA43 is more specific than BA40.

Differential Diagnoses

Pulmonary Embolism: May present with chest pain and dyspnea, but typically associated with pleuritic pain, disproportionate tachycardia, and risk factors for thromboembolism. Diagnostic tests (D-dimer, pulmonary computed tomography angiography) differ from those used for angina.

Aortic Dissection: Sudden, lancinating chest pain of maximum intensity at onset, frequently radiating to the back. There may be asymmetry of pulses or blood pressure between limbs. Imaging methods (computed tomography angiography, transesophageal echocardiography) confirm the diagnosis.

Acute Pericarditis: Chest pain typically pleuritic, worsening with deep inspiration and supine position, relieved by sitting upright leaning forward. Pericardial friction rub on auscultation, diffuse electrocardiographic changes (concave ST segment elevation), pericardial effusion on echocardiography.

Esophageal Spasm: May mimic angina, but generally related to swallowing, without clear relationship to physical exertion. May respond to nitrates (confusing with angina), but functional cardiac tests are negative. Upper endoscopy or esophageal manometry may confirm.

8. Differences with ICD-10

In the ICD-10 classification, angina pectoris was coded primarily as I20, with subdivisions: I20.0 (unstable angina), I20.1 (angina pectoris with documented spasm), I20.8 (other forms of angina pectoris), and I20.9 (angina pectoris, unspecified). This structure offered greater specification of the type of angina through the fourth character.

The main change in ICD-11 with code BA40 is the simplification of primary coding for angina pectoris, consolidating different presentations under a single code. While ICD-10 required mandatory differentiation between stable and unstable angina at the basic code level, ICD-11 allows this differentiation to be made through extensions or complementary clinical documentation, maintaining BA40 as the primary code.

This approach reflects evolution in clinical understanding that stable and unstable angina represent a continuous spectrum of the same underlying pathophysiology (reversible myocardial ischemia), differing primarily in severity and temporal pattern, but not necessarily requiring completely distinct codes for epidemiological and administrative purposes.

The practical impact of this change includes simplification of the coding process, reduction of errors related to incorrect classification among angina subtypes, and greater consistency in capturing epidemiological data on ischemic coronary artery disease. Health information systems need to adapt to capture clinical nuances through fields complementary to the primary code, maintaining the richness of clinical information that ICD-10 provided through specific subdivisions.

9. Frequently Asked Questions

How is angina pectoris diagnosed?

The diagnosis of angina pectoris is based primarily on detailed clinical history, identifying typical pain characteristics: quality (tightness, pressure, heaviness in the chest), retrosternal location, duration of a few minutes, triggering by physical exertion or emotional stress, and relief with rest or sublingual nitrates. Physical examination may be normal between episodes. Diagnostic confirmation requires complementary tests: electrocardiogram (may show ischemic changes during symptoms), exercise stress test, stress echocardiography, myocardial perfusion scintigraphy, or cardiac magnetic resonance imaging to document reversible ischemia. Cardiac biomarkers (troponins) should be normal, differentiating angina from myocardial infarction. In selected cases, coronary angiography or coronary angiography computed tomography anatomically evaluate the coronary arteries.

Is treatment available in public health systems?

Treatment of angina pectoris is generally available in public health systems in most countries, including essential medications such as nitrates, beta-blockers, calcium channel blockers, antiplatelet agents (aspirin), and statins. These medications are part of essential medicine lists in multiple health systems worldwide. Myocardial revascularization procedures (coronary angioplasty with stent or revascularization surgery) may have variable availability depending on local infrastructure and health system resources. Cardiac rehabilitation programs, risk factor modification, and specialized outpatient follow-up are also important components of comprehensive treatment, with availability varying according to local resources.

How long does treatment last?

Angina pectoris generally requires long-term treatment, often for the patient's lifetime. Antianginal medication therapy may be continuous for symptom control and prevention of cardiovascular events. Antiplatelet agents and statins are typically maintained indefinitely to reduce cardiovascular risk. After revascularization procedures (angioplasty or surgery), some medications may be adjusted, but are rarely discontinued completely. Regular medical follow-up is necessary to monitor therapeutic efficacy, adjust medications, evaluate disease progression, and modify risk factors. Patients with well-controlled stable angina may have longer follow-up intervals, while those with unstable or refractory symptoms require more frequent monitoring.

Can this code be used in medical certificates?

Yes, code BA40 can be used in medical certificates when work leave or activity limitation is necessary due to angina pectoris. Documentation should specify recommended functional limitations, estimated duration of leave, and activity restrictions. For work involving intense physical exertion, the certificate may recommend temporary or permanent leave, depending on the severity of angina and response to treatment. Activities that may trigger anginal episodes should be clearly identified. In some occupational contexts, especially critical safety professions (pilots, professional drivers), the presence of angina may require specialized functional fitness evaluation. Complete medical documentation, including diagnostic tests and functional capacity assessment, strengthens the certificate's justification.

Does angina pectoris always progress to myocardial infarction?

Not necessarily. Although angina pectoris indicates the presence of coronary artery disease and increases the risk of myocardial infarction, many patients with well-controlled stable angina do not develop infarction, especially when they adhere to appropriate medication therapy, control cardiovascular risk factors, and undergo regular medical follow-up. Unstable angina presents a higher risk of short-term progression to infarction, requiring urgent evaluation and treatment. Secondary prevention strategies (antiplatelet agents, statins, blood pressure control, smoking cessation, guided physical activity) significantly reduce the risk of major cardiovascular events. Revascularization procedures, when appropriate, can relieve symptoms and reduce risk in selected patients. Individual prognosis depends on multiple factors including extent of coronary artery disease, ventricular function, comorbidities, and response to treatment.

What is the difference between stable and unstable angina?

Stable angina is characterized by a predictable pattern of symptoms, triggered by a consistent level of physical exertion or emotional stress, with relatively constant duration and intensity over time, relieving promptly with rest or nitrates. It represents a situation of equilibrium between myocardial oxygen demand and supply, usually related to stable atherosclerotic plaques causing fixed coronary stenosis. Unstable angina manifests with recent onset (less than two months), increasing pattern (progressive increase in frequency, intensity, or duration of episodes), occurrence at rest or with minimal exertion, or early post-infarction angina. It represents disruption of ischemic equilibrium, frequently related to atherosclerotic plaque instability with partial thrombosis, indicating elevated risk of progression to infarction. Unstable angina requires urgent evaluation and treatment, frequently in a hospital setting.

Can young people have angina pectoris?

Although angina pectoris is more common in middle-aged and elderly individuals, young people can develop this condition, especially in the presence of significant risk factors such as heavy smoking, diabetes mellitus, arterial hypertension, familial dyslipidemia, obesity, or very early family history of coronary artery disease. Specific causes in young people include congenital coronary anomalies, vasospastic angina (Prinzmetal), use of illicit substances (cocaine, amphetamines), inflammatory conditions (Takayasu arteritis, Kawasaki disease), or hypercoagulable states. Diagnostic investigation in young people with symptoms suggestive of angina should be particularly careful, considering broad differential diagnoses and non-atherosclerotic causes of myocardial ischemia. Prognosis and therapeutic approach depend on the identified underlying etiology.

Is physical exercise contraindicated for people with angina?

Physical exercise is not absolutely contraindicated for patients with angina pectoris, but must be carefully prescribed and supervised. Regular physical activity, when appropriately guided, is a fundamental component of treatment, improving functional capacity, risk factor control, and quality of life. Supervised cardiac rehabilitation programs are ideal for patients with angina, allowing progressive exercise in a monitored environment. Exercise intensity should be individualized, generally maintained below the threshold that triggers anginal symptoms. Light to moderate intensity exercises are generally safe and beneficial. High-intensity or competitive activities may be contraindicated depending on the severity of coronary artery disease. Patients should be counseled about warning signs (chest pain, excessive dyspnea, dizziness) that indicate the need to stop exercise and seek medical evaluation.

Keywords: BA40, angina pectoris, ICD-11, ischemic heart disease, chest pain, myocardial ischemia, medical coding, international classification of diseases, stable angina, unstable angina, cardiovascular diagnosis, exercise stress test, myocardial revascularization, cardiovascular risk factors, coronary syndrome.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-03

Angina pectoris

Partager